Generics Products found!

Innovative

Biosimilars

Medical devices

Nutraceuticals Products found!

Filters

10 probiotic strains manufacturers

Filters

None products found

clopidogrel bisulfate + 10 probiotic strains

Tablets 75 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Manufacturer #19279

This company, based in South Asia, has been operating for over two decades, specializing in pharmaceuticals. It produces a wide range of products, including prescription drugs, over-the-counter medications, intravenous infusions, and bulk drug ingredients. They operate in both regulated and unregulated markets, exporting to regions like Europe, the Far East, and Latin America. The company boasts world-class manufacturing facilities, adhering to Good Manufacturing Practices (GMP) standards. While not explicitly stating specific therapy areas, their focus on IV solutions and bulk drug ingredients suggests a concentration on areas like oncology, cardiology, and critical care. The company's production lines include a variety of dosage forms such as solids, liquids, and injectables.

Manufacturer usually replies in 34 days

trypsin-chymotrypsin + 10 probiotic strains

Tablets 50000 IU, 200000 IU

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18722
This pharmaceutical manufacturer boasts decades of experience in the industry, providing a broad range of affordable finished formulations, including prescription drugs, OTC medications, and supplements. They offer turnkey manufacturing, technology transfer, contract development and manufacturing services, as well as co-development and co-marketing options. Key therapy areas include chronic and acute therapies, OTCs, and complex formulations. Dosage forms include tablets, capsules, syrups, powders, liquids, injections, and ointments. They have obtained GMP approvals from regulatory bodies in the EU, North America, and other regions, demonstrating their commitment to quality and compliance. The company's global presence extends to key regions like North America, Asia, and Africa, solidifying their position as a trusted partner in the pharmaceutical industry.

Manufacturer usually replies in 13 days

albumin human + 10 probiotic strains

Solution for infusion 20 % - 50 ml, 100 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Turkey
GMP approvals
EU GMP, Turkey
Manufacturer #10966
It is a well-known international pharmaceutical company with operations in more than 15 countries. Orphan illness, plasma products, hospital injectables, vaccines, and particular OTC products are among the company's specialties. The company, which believes that every patient deserves current treatment options and a great quality of life, formed its R&D department in the 2010s and has been working hard since to develop and produce specialized products.

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

CLOPIDOGREL BISULFATE

Clopidogrel bisulfate is an anti-platelet medication. It inhibits platelet aggregation and thus inhibits aspects of blood clotting. It is used to treat patients with acute coronary syndrome, myocardial infarction, peripheral vascular disease and ischemic type strokes. It is effective in preventing strokes, heart attacks, and death in individuals who have had a previous stroke, unstable angina, heart attack or have a peripheral arterial disease. It works by blocking platelets from sticking together and prevents harmful clots. It helps keep blood flowing smoothly in the body. It is a thienopyridine class of drug. It is combined with aspirin than alone in preventing another heart attack. Clopidogrel bisulfate is sold under the brand name Plavix amongst others. Bristol-Myers Squibb in collaboration with Sanofi-Aventis developed and manufactured Clopidogrel bisulfate. The US Food and Drug Administration first approved it in 1997.

Forms and dose:

Clopidogrel bisulfate is available as 75 and 300 mg tablets. In the treatment of acute coronary syndrome with a non-ST elevation MI, the initial dose is 300 mg per day. This is followed up by a 75 mg dose per day but for treating ST elevation MIs, the initial and continuing dose is recommended to keep at 75 mg per day.

The price of Clopidogrel bisulfate:

In the USA, consumers have to pay an average price of $30.00 for 30 Tablets of 75mg each. Whereas the price of this medicine is significantly cheaper in the developing world. The price of for the same supply of 30 tablets of 75mg cost only US$4.

How does it work?

Clopidogrel actions prevent blood clots. It does this by irreversibly binding to the receptor on platelets, preventing adenosine diphosphate from activating platelets. As a P2Y12 inhibitors. Eventually, the platelets exposed to clopidogrel’s active metabolite are inhibited for the remainder of their lifespan, which is about 7 to 10 days.

Finding Clopidogrel bisulfate Manufacturers and Suppliers

The best way to find and gain access to Clopidogrel bisulfate manufacturers and Clopidogrel bisulfate suppliers is to make through Pipelinepharma's global B2B online marketplace for medicines and other pharmaceuticals. Normally, finding trusted manufacturers and supplies of specific drugs like Clopidogrel bisulfate can be a time-consuming challenge, but with Pipelinepharma's simple search engine and network of proven partners, the whole process becomes a lot easier.
All you need to do to get started is to make use of our integrated search engine and start looking for suppliers or manufacturers of Clopidogrel bisulfate to work with. You can fine-tune your search results using various filters too, letting you search for Clopidogrel bisulfate from specific countries, for example.

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.